Repoxegen Therapeutics. Inc
- Biotech or pharma, therapeutic R&D
We are developing a breakthrough oral drug (at pre-IND stage) to treat diabetic retinopathy and other retinal and neuro-degenerative diseases by targeting disequilibrium in fatty acid metabolism that leads to neuroinflammation and degenerative cell disease.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}